| 英文品名 |
cantuzumab mertansine |
| 名稱(chēng)來(lái)源 |
p-INNList-89,2003;r-INNList-51,2004; |
| 別 名 |
SB-408075，huC242-DM1 |
| 化學(xué)表述 |
immunoglobulin G1, anti-(mucin CanAg) (human-mouse monoclonal C242 heavy chain), disulfide with human-mouse monoclonal C242 light chain, dimer, conjugate at the 6-amino groups of four lysine residues forming an amide bond with (4RS)-4-[(3-{[(1S)-2-{[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy}-1-methyl-2-oxoethyl]methylamino}-3-oxopropyl)disulfanyl]pentanoyl groups |
| CA登記號(hào) |
400010-39-1 |
| 結(jié) 構(gòu) 式 |
 |
| 品種類(lèi)別 |
抗腫瘤藥>單克隆抗體類(lèi) |
|
